The drumbeat of calls to enact reforms to pharmaceutical middlemen is growing louder after years of largely unsuccessful attempts by lawmakers to make sweeping changes to how the industry operates — and reform advocates hope that conditions are ripe this year for action. Megan R. Wilson talks with host Ruth Reader about the bills that have been introduced and how PBMs are fighting back.

Learn more about your ad choices. Visit megaphone.fm/adchoices